CCMIC
GILD icon

Cardinal Capital Management Inc (Canada)’s Gilead Sciences GILD Stock Holding History

Cardinal Capital Management Inc (Canada)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,250
Closed -$252K – 69
2025
Q1 		$252K Sell
2,250
-10,325
-82% -$1.07M 0.01% 68
2024
Q4 		$1.16M Sell
12,575
-7,673
-38% -$691K 0.04% 59
2024
Q3 		$1.7M Sell
20,248
-170,135
-89% -$13M 0.07% 49
2024
Q2 		$13.1M Buy
190,383
+1,163
+0.6% +$77.6K 0.5% 47
2024
Q1 		$13.9M Buy
189,220
+8,930
+5% +$687K 0.62% 41
2023
Q4 		$14.6M Sell
180,290
-2,385
-1% -$186K 0.69% 38
2023
Q3 		$13.7M Buy
182,675
+555
+0.3% +$42.7K 0.71% 38
2023
Q2 		$14M Sell
182,120
-1,635
-0.9% -$130K 0.7% 38
2023
Q1 		$15.2M Sell
183,755
-1,555
-0.8% -$129K 0.83% 35
2022
Q4 		$15.9M Buy
185,310
+4,410
+2% +$349K 0.9% 34
2022
Q3 		$11.2M Buy
180,900
+4,360
+2% +$275K 0.68% 37
2022
Q2 		$10.9M Sell
176,540
-89,830
-34% -$5.56M 0.6% 39
2022
Q1 		$15.8M Buy
266,370
+24,230
+10% +$1.55M 0.77% 36
2021
Q4 		$17.6M Buy
242,140
+16,600
+7% +$1.14M 0.82% 34
2021
Q3 		$15.8M Buy
225,540
+8,360
+4% +$587K 0.86% 32
2021
Q2 		$15M Buy
217,180
+19,537
+10% +$1.3M 0.81% 35
2021
Q1 		$12.8M Buy
197,643
+40,708
+26% +$2.62M 0.75% 35
2020
Q4 		$9.14M Buy
156,935
+12,385
+9% +$747K 0.56% 40
2020
Q3 		$9.13M Buy
144,550
+21,645
+18% +$1.5M 0.65% 39
2020
Q2 		$9.46M Buy
122,905
+24,500
+25% +$1.88M 0.8% 34
2020
Q1 		$7.36M Buy
+98,405
New +$6.8M 0.61% 36

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cardinal Capital Management Inc (Canada)'s GILD Position: Q2 2025 in Review

Cardinal Capital Management Inc (Canada) sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 2,250 shares — an estimated $252K sold.

Cardinal Capital Management Inc (Canada) first reported a position in GILD in Q1 2020 and held it in 21 quarters. The position peaked at $17.6M in Q4 2021. 2,025 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Cardinal Capital Management Inc (Canada) reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Cardinal Capital Management Inc (Canada) sold 2,250 Gilead Sciences shares in Q2 2025, an estimated $252K.
  • Cardinal Capital Management Inc (Canada) first reported a position in Gilead Sciences in Q1 2020 and held it in 21 quarters.
  • Cardinal Capital Management Inc (Canada)'s Gilead Sciences position peaked at $17.6M in Q4 2021.
  • 2,025 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Cardinal Capital Management Inc (Canada)'s 13F filing for Q2 2025, filed 11 Jul 2025.